Printed From:

QUESTIONS ABOUT NOVEL CORONAVIRUS?
CLICK HERE.

An extensive clinical trial programme

  • ADULTS AND ADOLESCENTS:
    DUPIXENT was studied in one Phase 2b and two Phase 3 clinical trials including 2,888 patients aged 12 years and older, for up to 52 weeks1

INTRODUCING THE DUPIXENT PRE-FILLED PEN

A convenient option to ensure patients
administer DUPIXENT as directed1

References

  1. Sanofi Genzyme. Dupixent Summary of Product Characteristics, May 2021.